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Chronic Discoid Lupus
An uncommon cause of nail atrophy
*Francisco J. Navarro-Triviño1 and Ricardo Ruiz-Villaverde2
A 45 year-old woman presented to the outpatient dermatology clinic of the Hospital Alcalá la Real, Jaén, Spain, in 2017 complaining 
of recent changes to the distal phalanx of the third and 
fourth finger of her right hand and the fourth finger 
of her left one. She had a history of discoid lupus eryth-
ematosus (DLE) and Sjögren syndrome (SS) without 
Raynaud’s phenomenon. A clinical examination revealed 
atrophic changes associated with milky-red patches on 
the affected areas [Figure 1]. The status of the toenails was 
normal. The patient did not show palmoplantar hyper- 
keratosis and there was no evidence of mucous membrane 
ulceration.
The patient underwent a series of laboratory tests 
which revealed an antinuclear antibody titre of 1/640 with 
granular and nuclear patterns, anti-SS-related antigen A/ 
Ro52 level of >240 U/mL, anti-SS-related antigen B/La 
level of >320 U/mL and rheumatoid factor level of 
72.7 UI/mL. However, complement, anti-histidyl trans- 
fer ribonucleic acid synthetase, antiscleroderma 70, 
antiphospholipid and thrombophilia tests were normal. 
In addition, thyroid function was normal. Nailfold capill-
aroscopy was performed using a 3Gen DermLite® 
dermascope (3Gen Inc., San Juan Capistrano, California, 
USA) in polarised mode at x10 magnification. This 
showed dilated and elongated capillaries, increased 
tortuosities and avascular areas [Figure 2]. These changes 
were associated with nail pterygium. Onychomycosis 
was ruled out by a negative dermatophyte culture.
Comment
First described by Gilliam et al. in 1981, DLE is a chronic 
scarring skin condition and a common form of cutaneous 
lupus in European populations.1–3 The condition usually 
has a severe effect on quality of life and emotional well- 
being.2,3 Dermoscopy of facial and extra-scalp DLE lesions 
shows varying features according to disease stage. 
Erythematous perifollicular whitish ‘halos’, follicular 
keratotic plugs, red dots and white scaling are common 
features in early lesions, while whitish structureless areas 
and hyperpigmentation (e.g. in a ‘honeycomb’ or peri- 
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Figure 1: Photograph of the fourth fingernail of the left hand of a 45 year-old woman with discoid lupus erythematosus 
and Sjögren syndrome showing atrophic changes and whitish cuticles.
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Nail dystrophy in DLE may allow for the identif-
ication of patients with severe conditions and high dam- 
age indices. The differential diagnosis of DLE-related 
nail dystrophy should include onychomycosis—ruled 
out in the current case—psoriasis, lichen planus, Darier’s 
disease and nail trauma.10 A skin biopsy is often not 
necessary if other discoid skin lesions are present, as 
in the current case; however, it can be performed in 
cases wherein the clinical diagnosis is not consistent 
with DLE. 
In terms of topical treatment, clobetasol propionate 
lacquer, tazarotene cream and tacrolimus ointment 
may result in a partial therapeutic response.11 However, 
combining this approach with systemic treatment such 
as methotrexate has produced better response rates. 
In addition, antiplatelets and/or anticoagulant agents 
should be considered.5 
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follicular pattern) are frequently observed in late phases.4 
Ungual involvement is not common. Clinically, DLE 
usually presents as a well-delimited plaque with red and 
white areas and is associated with skin and nail trophic 
changes.5
Capillaroscopy is considered the gold-standard 
technique to evaluate the microvasculature in the prox- 
imal area of the nailfold.6 Giant capillaries, haemorrhage, 
avascular areas and neoangiogenesis are considered 
scleroderma-type features of systemic lupus erythem-
atosus (SLE), rather than DLE.7 Correlations have been 
demonstrated between capillaroscopic abnormalities in 
SLE and Raynaud’s phenomenon, disease activity, endo- 
thelial cell activation markers and certain autoantibodies, 
such as anticardiolipin, anti-U1-ribonucleoprotein, anti- 
Smith and anti-double stranded DNA antibodies.6,8 
In affected cases where capillaroscopy is not feasible, 
examination of the nail via routine dermoscopy may 
provide important information. Although nailfold dermo- 
scopic features may not be specific to DLE, these feat- 
ures have been associated with higher disease activity and 
internal organ involvement and suggest an important 
role for chronic microvascular damage in the clinical 
development of systemic autoimmune disease.7 Urowitz 
et al. described common nail features among patients 
affected by SLE.9 However, little has been published 
regarding nail trophic changes among patients with DLE.
 
Figure 2: Capillaroscopy images of the fingernail of a 45 
year-old woman with discoid lupus erythematosus and 
Sjögren syndrome showing (A) dystrophic tent-shaped 
changes in the nail (arrow) as well as distal onycholysis 
associated with fine superficial desquamation and pointed 
vessels in the hyponychium (arrowhead) and (B) white 
avascular areas (arrow) and elongated tortuous capill-
aries (arrowhead) in the eponychium.
